Exploratory biomarker analysis for predicting treatment effects of aflibercept in the VELOUR trial.

被引:0
|
作者
Pu, Ting
Peddle, Allyson
Wirapati, Pratyaksha
Hong, Yourae
Samuel, Leslie
Desai, Jayesh
Riener, Maigo
Saridaki, Zacharenia
Cunningham, David
Tejpar, Sabine
Tsantoulis, Petros
机构
[1] Katholieke Univ Leuven, Leuven, Belgium
[2] Swiss Inst Bioinformat, Lausanne, Switzerland
[3] Aberdeen Royal Infirm, Aberdeen, Scotland
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] Docrates Canc Hosp Helsinki, Helsinki, Finland
[6] Metropolitan Hosp, Athens, Greece
[7] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[8] Katholieke Univ Leuven, UZ Gasthuisberg, Leuven, Belgium
[9] Geneva Univ Hosp, Geneva, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3592
引用
收藏
页数:1
相关论文
共 50 条
  • [31] The substitution of carvedilol for metoprolol in the treatment of systolic heart failure: An economic analysis of the COMET Trial.
    Cykert, S
    Greene, S
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 : 226 - 226
  • [32] Effects of ghrelin treatment on exertional dyspnea in COPD: an exploratory analysis
    Miki, Keisuke
    Maekura, Ryoji
    Nagaya, Noritoshi
    Miki, Mari
    Kitada, Seigo
    Yoshimura, Kenji
    Mori, Masahide
    Kangawa, Kenji
    Journal of Physiological Sciences, 2015, 65 (03): : 277 - 284
  • [33] Effects of ghrelin treatment on exertional dyspnea in COPD: an exploratory analysis
    Keisuke Miki
    Ryoji Maekura
    Noritoshi Nagaya
    Mari Miki
    Seigo Kitada
    Kenji Yoshimura
    Masahide Mori
    Kenji Kangawa
    The Journal of Physiological Sciences, 2015, 65 : 277 - 284
  • [34] Quantitative analysis of tumor vascular targeting: Effects of endostatin in a phase I clinical trial.
    Davis, DW
    Mullani, N
    Hess, KR
    Tseng, J
    O'Reilly, M
    Herbst, RS
    Abbruzzese, JL
    McConkey, DJ
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3711S - 3711S
  • [35] Exploratory analysis of treatment response trajectories in the PRISM trial: Models of psychosocial care
    Lau, Nancy
    Bradford, Miranda C.
    Steineck, Angela
    Junkins, Courtney C.
    Yi-Frazier, Joyce P.
    McCauley, Elizabeth
    Rosenberg, Abby R.
    PSYCHO-ONCOLOGY, 2019, 28 (07) : 1470 - 1476
  • [36] Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis
    Fang, Zijian
    Fattori, Giuditta Corbizi
    Mckerrell, Thomas
    Boucher, Rebecca H.
    Jackson, Aimee
    Fletcher, Rachel S.
    Forte, Dorian
    Martin, Jose-Ezequiel
    Fox, Sonia
    Roberts, James
    Glover, Rachel
    Harris, Erica
    Bridges, Hannah R.
    Grassi, Luigi
    Rodriguez-Meira, Alba
    Mead, Adam J.
    Knapper, Steven
    Ewing, Joanne
    Butt, Nauman M.
    Jain, Manish
    Francis, Sebastian
    Clark, Fiona J.
    Coppell, Jason
    Mcmullin, Mary F.
    Wadelin, Frances
    Narayanan, Srinivasan
    Milojkovic, Dragana
    Drummond, Mark W.
    Sekhar, Mallika
    Eldaly, Hesham
    Hirst, Judy
    Paramor, Maike
    Baxter, E. Joanna
    Godfrey, Anna L.
    Harrison, Claire N.
    Mendez-Ferrer, Simon
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [37] Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis
    Zijian Fang
    Giuditta Corbizi Fattori
    Thomas McKerrell
    Rebecca H. Boucher
    Aimee Jackson
    Rachel S. Fletcher
    Dorian Forte
    Jose-Ezequiel Martin
    Sonia Fox
    James Roberts
    Rachel Glover
    Erica Harris
    Hannah R. Bridges
    Luigi Grassi
    Alba Rodriguez-Meira
    Adam J. Mead
    Steven Knapper
    Joanne Ewing
    Nauman M. Butt
    Manish Jain
    Sebastian Francis
    Fiona J. Clark
    Jason Coppell
    Mary F. McMullin
    Frances Wadelin
    Srinivasan Narayanan
    Dragana Milojkovic
    Mark W. Drummond
    Mallika Sekhar
    Hesham ElDaly
    Judy Hirst
    Maike Paramor
    E. Joanna Baxter
    Anna L. Godfrey
    Claire N. Harrison
    Simón Méndez-Ferrer
    Nature Communications, 14
  • [38] Moderators of Varenicline Treatment Effects in a Double-Blind, Placebo-Controlled Trial for Alcohol Dependence: An Exploratory Analysis
    Falk, Daniel E.
    Castle, I-Jen P.
    Ryan, Megan
    Fertig, Joanne
    Litten, Raye Z.
    JOURNAL OF ADDICTION MEDICINE, 2015, 9 (04) : 296 - 303
  • [39] Impact of prior bevacizumab treatment on VEGFA and PlGF levels and patient outcomes: A retrospective analysis of baseline plasma samples from the VELOUR trial
    Eric, Van Cutsem
    Emmanuelle, Dochy
    Caroline, Paccard
    Marielle, Chiron
    Josep, Tabernero
    ANNALS OF ONCOLOGY, 2017, 28
  • [40] Ziv-aflibercept (A) combined to FOLFIRI as first line treatment for metastatic colorectal cancer (mCRC): Interim safety and efficacy results of the phase II PULSAR trial.
    Adenis, Antoine
    Ghiringhelli, Francois
    Raoul, Jean Luc
    Tresch, Emmanuelle
    Thirot-Bidault, Anne
    Vincent, Julie
    El Hajbi, Farid
    Hebbar, Mohamed
    Bouchahda, Mohamed
    Jarraya, Hajer
    Feutray, Sylvaine
    Amela, Eric
    Laestadius, Fredrik
    Le Deley, Marie-Cecile
    Taieb, Sophie
    Soncin, Fabrice
    Dochy, Emmanuelle
    Delaine, Stephanie Clisant
    Penel, Nicolas
    Lassau, Nathalie
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)